Education
About Us
Working with TipRanks
Follow Us
Britannia Life Sciences Inc (TSE:BLAB)
:BLAB
RESEARCH TOOLSreports
BLAB Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.03 - C$0.12
Previous CloseN/A
Volume35.00K
Average Volume (3M)195.23K
Market Cap
C$13.79M
Enterprise ValueC$23.69M
Total Cash (Recent Filing)C$990.37K
Total Debt (Recent Filing)C$7.11M
Price to Earnings (P/E)―
Beta-0.78
Next Earnings
Jul 30, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding162,254,330
10 Day Avg. Volume145,802
30 Day Avg. Volume195,232
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Britannia Life Sciences Inc News
BLAB FAQ
What was Britannia Life Sciences Inc’s price range in the past 12 months?
Britannia Life Sciences Inc lowest stock price was C$0.03 and its highest was C$0.12 in the past 12 months.
What is Britannia Life Sciences Inc’s market cap?
Britannia Life Sciences Inc’s market cap is C$13.79M.
When is Britannia Life Sciences Inc’s upcoming earnings report date?
Britannia Life Sciences Inc’s upcoming earnings report date is Jul 30, 2025 which is 15 days ago.
How were Britannia Life Sciences Inc’s earnings last quarter?
Currently, no data Available
Is Britannia Life Sciences Inc overvalued?
According to Wall Street analysts Britannia Life Sciences Inc’s price is currently Overvalued.
Does Britannia Life Sciences Inc pay dividends?
Britannia Life Sciences Inc does not currently pay dividends.
What is Britannia Life Sciences Inc’s EPS estimate?
Britannia Life Sciences Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Britannia Life Sciences Inc have?
Britannia Life Sciences Inc has 162,254,330 shares outstanding.
What happened to Britannia Life Sciences Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Britannia Life Sciences Inc?
Currently, no hedge funds are holding shares in TSE:BLAB
Company Description
Britannia Life Sciences Inc
Britannia Life Sciences Inc. provides product testing, safety assessment, and compliance services to the cosmetics, nutraceutical, and consumer packaged goods industries in the United Kingdom and internationally. The company is based in Toronto, Canada.
Technical Analysis
Kane Biotech
―
Resverlogix
―
Tetra Bio-Pharma
―
BetterLife Pharma
―
BioVaxys Technology
―
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.23% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---